Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Boston Scientific exercises option to acquire Farapulse » 07:02
06/24/21
06/24
07:02
06/24/21
07:02
BSX

Boston Scientific

$43.81 /

-0.035 (-0.08%)

Boston Scientific…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BSX Boston Scientific
$43.81 /

-0.035 (-0.08%)

BSX Boston Scientific
$43.81 /

-0.035 (-0.08%)

06/07/21 Argus
Boston Scientific price target raised to $50 from $45 at Argus
05/26/21
Fly Intel: Top five analyst downgrades
05/26/21 Needham
Boston Scientific downgraded to Hold at Needham on overextended consensus
05/26/21 Needham
Boston Scientific downgraded to Hold from Buy at Needham
BSX Boston Scientific
$43.81 /

-0.035 (-0.08%)

BSX Boston Scientific
$43.81 /

-0.035 (-0.08%)

BSX Boston Scientific
$43.81 /

-0.035 (-0.08%)

Monday
Options
Boston Scientific call buyer realizes 132% same-day gains » 08:00
06/21/21
06/21
08:00
06/21/21
08:00
BSX

Boston Scientific

$43.02 /

-0.32 (-0.74%)

Notable profits for the…

Notable profits for the buyer who lifted the $0.17 offer for 8,000 Boston Scientific (BSX) Jul-21 47 calls yesterday at 11:27ET when underlying shares were trading at $42.90. Shares closed at $43.02, and the calls at $0.40 for a mark-to-market profit of 132%, or $180K, on the $136K outlay.

ShowHide Related Items >><<
BSX Boston Scientific
$43.02 /

-0.32 (-0.74%)

BSX Boston Scientific
$43.02 /

-0.32 (-0.74%)

06/07/21 Argus
Boston Scientific price target raised to $50 from $45 at Argus
05/26/21
Fly Intel: Top five analyst downgrades
05/26/21 Needham
Boston Scientific downgraded to Hold at Needham on overextended consensus
05/26/21 Needham
Boston Scientific downgraded to Hold from Buy at Needham
BSX Boston Scientific
$43.02 /

-0.32 (-0.74%)

BSX Boston Scientific
$43.02 /

-0.32 (-0.74%)

BSX Boston Scientific
$43.02 /

-0.32 (-0.74%)

Friday
Options
Boston Scientific call volume above normal and directionally bullish » 13:05
06/18/21
06/18
13:05
06/18/21
13:05
BSX

Boston Scientific

$43.17 /

-0.17 (-0.39%)

Bullish option flow…

Bullish option flow detected in Boston Scientific with 14,896 calls trading, 3x expected, and implied vol increasing over 2 points to 23.86%. Jul-21 47 calls and Jul-21 45 calls are the most active options, with total volume in those strikes near 11,800 contracts. The Put/Call Ratio is 0.17. Earnings are expected on July 28th.

ShowHide Related Items >><<
BSX Boston Scientific
$43.17 /

-0.17 (-0.39%)

BSX Boston Scientific
$43.17 /

-0.17 (-0.39%)

06/07/21 Argus
Boston Scientific price target raised to $50 from $45 at Argus
05/26/21
Fly Intel: Top five analyst downgrades
05/26/21 Needham
Boston Scientific downgraded to Hold at Needham on overextended consensus
05/26/21 Needham
Boston Scientific downgraded to Hold from Buy at Needham
BSX Boston Scientific
$43.17 /

-0.17 (-0.39%)

BSX Boston Scientific
$43.17 /

-0.17 (-0.39%)

BSX Boston Scientific
$43.17 /

-0.17 (-0.39%)

Over a week ago
Recommendations
Boston Scientific price target raised to $50 from $45 at Argus » 08:07
06/07/21
06/07
08:07
06/07/21
08:07
BSX

Boston Scientific

$42.04 /

+0.69 (+1.67%)

Argus analyst Jasper…

Argus analyst Jasper Hellweg raised the firm's price target on Boston Scientific to $50 from $45 and keeps a Buy rating on the shares. The analyst cites the company's recent Q1 earnings beat, also noting that the company's sales were stronger in all three of its segments for the first time since Q4 of 2019. The spread of coronavirus vari-nts and the slow pace of vaccinations in some overseas markets may delay a return to full pre-pandemic activity, but Boston Scientific should benefit as more patients return to doctors' offices and other medical facilities as vaccination rates increase and the risk of community transmission diminishes, Hellweg tells investors in a research note.

ShowHide Related Items >><<
BSX Boston Scientific
$42.04 /

+0.69 (+1.67%)

BSX Boston Scientific
$42.04 /

+0.69 (+1.67%)

05/26/21
Fly Intel: Top five analyst downgrades
05/26/21 Needham
Boston Scientific downgraded to Hold at Needham on overextended consensus
05/26/21 Needham
Boston Scientific downgraded to Hold from Buy at Needham
05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
BSX Boston Scientific
$42.04 /

+0.69 (+1.67%)

BSX Boston Scientific
$42.04 /

+0.69 (+1.67%)

BSX Boston Scientific
$42.04 /

+0.69 (+1.67%)

Downgrade
Fly Intel: Top five analyst downgrades » 09:55
05/26/21
05/26
09:55
05/26/21
09:55
CCK

Crown Holdings

$101.84 /

-6.31 (-5.83%)

, BLL

Ball Corp.

$82.45 /

-3.42 (-3.98%)

, ARD

Ardagh Group

$24.91 /

-0.52 (-2.04%)

, ITW

Illinois Tool Works

$230.17 /

-2.34 (-1.01%)

, AMC

AMC Entertainment

$17.94 /

+1.525 (+9.29%)

, BSX

Boston Scientific

$41.75 /

-1.28 (-2.97%)

, TVTX

Travere Therapeutics

$15.18 /

-2.6 (-14.62%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Crown Holdings (CCK), Ball Corp. (BLL) and Ardagh Group (ARD) all downgraded to Market Perform from Outperform at BMO Capital following news that Can-Pack is building a second U.S. beverage can plant in Indiana. 2. Illinois Tool Works (ITW) downgraded to Underweight from Equal Weight at Barclays with analyst Julian Mitchell seeing catalysts to drive a reversal of the stock's recent bounce, including organic sales growth decelerating in most of the company's businesses back to prior peak levels by late 2021, evidence that its share gain efforts are not necessarily gaining traction and the potential levelling off in the "recently-stellar" incremental margins as input cost pressures ratchet higher. 3. AMC Entertainment (AMC) downgraded to Neutral from Buy at B. Riley with analyst Eric Wold saying while he remains confident about a box office recovery into 2022 and 2023 and still sees an opportunity for AMC to gain share, his rating change is based "on valuation only" with a 75% move higher in the shares pushing them above his $16 target. 4. Boston Scientific (BSX) downgraded to Hold from Buy at Needham with analyst Mike Matson contending that consensus estimates for the company's 2022 and 2023 performance look "too high," anticipating downward revisions going into and out of Boston Scientific's investor day in September. 5. Travere Therapeutics (TVTX) downgraded to Neutral from Outperform at Wedbush with analyst Laura Chico noting that Travere announced the FDA did not see interim DUPLEX data as adequate to form the basis for an accelerated approval filing. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
TVTX Travere Therapeutics
$15.18 /

-2.6 (-14.62%)

ITW Illinois Tool Works
$230.17 /

-2.34 (-1.01%)

CCK Crown Holdings
$101.84 /

-6.31 (-5.83%)

BSX Boston Scientific
$41.75 /

-1.28 (-2.97%)

BLL Ball Corp.
$82.45 /

-3.42 (-3.98%)

ARD Ardagh Group
$24.91 /

-0.52 (-2.04%)

AMC AMC Entertainment
$17.94 /

+1.525 (+9.29%)

CCK Crown Holdings
$101.84 /

-6.31 (-5.83%)

05/25/21 BMO Capital
Crown Holdings downgraded to Market Perform from Outperform at BMO Capital
05/25/21 Citi
Canpack U.S. plant news a negative for Ball and Crown, says Citi
05/25/21 BMO Capital
Crown Holdings price target raised to $125 from $120 at BMO Capital
05/20/21 Longbow
Crown Holdings initiated with a Buy at Longbow
BLL Ball Corp.
$82.45 /

-3.42 (-3.98%)

05/25/21 BMO Capital
Ball Corp. downgraded to Market Perform from Outperform at BMO Capital
05/20/21
Fly Intel: Top five analyst initiations
05/20/21 Longbow
Ball Corp. initiated with a Buy at Longbow
ARD Ardagh Group
$24.91 /

-0.52 (-2.04%)

05/25/21 BMO Capital
Ardagh Group downgraded to Market Perform from Outperform at BMO Capital
02/25/21 Wells Fargo
Ardagh Group upgraded to Overweight from Underweight at Wells Fargo
02/19/21 Barclays
Ardagh Group price target raised to $23 from $18 at Barclays
02/17/21 Deutsche Bank
Ardagh Group price target raised to $24 from $21 at Deutsche Bank
ITW Illinois Tool Works
$230.17 /

-2.34 (-1.01%)

05/26/21 Barclays
Illinois Tool Works downgraded to Underweight from Equal Weight at Barclays
05/05/21 Argus
Illinois Tool Works price target raised to $260 from $230 at Argus
05/03/21 Credit Suisse
Illinois Tool Works price target raised to $261 from $242 at Credit Suisse
05/03/21 Deutsche Bank
Illinois Tool Works price target raised to $227 from $217 at Deutsche Bank
AMC AMC Entertainment
$17.94 /

+1.525 (+9.29%)

05/26/21 B. Riley
AMC Entertainment downgraded to Neutral from Buy at B. Riley
05/25/21 Citi
Citi boosts AMC target to $3.70, says shares remain overvalued
05/14/21 B. Riley
AMC Entertainment price target raised to $16 from $13 at B. Riley
04/16/21 B. Riley
AMC CEO update on share issuance a positive, says B. Riley
BSX Boston Scientific
$41.75 /

-1.28 (-2.97%)

05/26/21 Needham
Boston Scientific downgraded to Hold at Needham on overextended consensus
05/26/21 Needham
Boston Scientific downgraded to Hold from Buy at Needham
05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Boston Scientific initiated with an Overweight at Barclays
TVTX Travere Therapeutics
$15.18 /

-2.6 (-14.62%)

05/26/21 BMO Capital
Travere Therapeutics price target lowered to $33 from $38 at BMO Capital
05/26/21 SVB Leerink
Travere Therapeutics price target lowered to $27 from $35 at SVB Leerink
05/26/21 Wedbush
Travere Therapeutics downgraded to Neutral at Wedbush on regulatory update
05/26/21 Evercore ISI
Travere Therapeutics price target lowered to $23 from $30 at Evercore ISI
TVTX Travere Therapeutics
$15.18 /

-2.6 (-14.62%)

ITW Illinois Tool Works
$230.17 /

-2.34 (-1.01%)

CCK Crown Holdings
$101.84 /

-6.31 (-5.83%)

BSX Boston Scientific
$41.75 /

-1.28 (-2.97%)

BLL Ball Corp.
$82.45 /

-3.42 (-3.98%)

ARD Ardagh Group
$24.91 /

-0.52 (-2.04%)

AMC AMC Entertainment
$17.94 /

+1.525 (+9.29%)

  • 12
    Feb
CCK Crown Holdings
$101.84 /

-6.31 (-5.83%)

BLL Ball Corp.
$82.45 /

-3.42 (-3.98%)

AMC AMC Entertainment
$17.94 /

+1.525 (+9.29%)

TVTX Travere Therapeutics
$15.18 /

-2.6 (-14.62%)

ITW Illinois Tool Works
$230.17 /

-2.34 (-1.01%)

CCK Crown Holdings
$101.84 /

-6.31 (-5.83%)

BSX Boston Scientific
$41.75 /

-1.28 (-2.97%)

BLL Ball Corp.
$82.45 /

-3.42 (-3.98%)

AMC AMC Entertainment
$17.94 /

+1.525 (+9.29%)

BSX Boston Scientific
$41.75 /

-1.28 (-2.97%)

AMC AMC Entertainment
$17.94 /

+1.525 (+9.29%)

Options
Unusually active option classes on open May 26th » 09:40
05/26/21
05/26
09:40
05/26/21
09:40
NBRV

Nabriva Therapeutics

$1.50 /

+ (+0.00%)

, SIRI

Sirius XM

$6.00 /

+ (+0.00%)

, EXPR

Express

$3.95 /

+ (+0.00%)

, BSX

Boston Scientific

$43.03 /

-0.005 (-0.01%)

, PDD

Pinduoduo

$130.83 /

+0.02 (+0.02%)

, AMC

AMC Entertainment

$16.41 /

-0.005 (-0.03%)

, BB

BlackBerry

$8.59 /

+ (+0.00%)

, GME

GameStop

$209.31 /

+ (+0.00%)

, F

Ford

$12.81 /

+ (+0.00%)

, GPS

Gap

$32.67 /

+ (+0.00%)

Unusual total active…

Unusual total active option classes on open include: Nabriva Therapeutics (NBRV), Sirius XM (SIRI), Express (EXPR), Boston Scientific (BSX), Pinduoduo (PDD), AMC Entertainment (AMC), BlackBerry (BB), GameStop (GME), Ford (F), and Gap (GPS).

ShowHide Related Items >><<
SIRI Sirius XM
$6.00 /

+ (+0.00%)

PDD Pinduoduo
$130.83 /

+0.02 (+0.02%)

NBRV Nabriva Therapeutics
$1.50 /

+ (+0.00%)

GPS Gap
$32.67 /

+ (+0.00%)

GME GameStop
$209.31 /

+ (+0.00%)

F Ford
$12.81 /

+ (+0.00%)

EXPR Express
$3.95 /

+ (+0.00%)

BSX Boston Scientific
$43.03 /

-0.005 (-0.01%)

BB BlackBerry
$8.59 /

+ (+0.00%)

AMC AMC Entertainment
$16.41 /

-0.005 (-0.03%)

NBRV Nabriva Therapeutics
$1.50 /

+ (+0.00%)

03/12/21 Northland
Nabriva Therapeutics price target lowered to $6 from $9 at Northland
06/22/20 Northland
Nabriva Therapeutics price target lowered to $1.50 from $2.50 at Northland
SIRI Sirius XM
$6.00 /

+ (+0.00%)

02/03/21 Citi
Tax sharing agreement 'very bullish' for Liberty SiriusXM, says Citi
01/28/21
Fly Intel: Top five analyst downgrades
01/28/21 Credit Suisse
Sirius XM downgraded to Neutral after rally at Credit Suisse
01/27/21 Credit Suisse
Sirius XM downgraded to Neutral from Outperform at Credit Suisse
EXPR Express
$3.95 /

+ (+0.00%)

03/11/21 B. Riley
Express price target raised to $3.50 from $1.50 at B. Riley Securities
01/15/21 B. Riley
Express price target raised to $1.50 from $1 at B. Riley Securities
BSX Boston Scientific
$43.03 /

-0.005 (-0.01%)

05/26/21 Needham
Boston Scientific downgraded to Hold at Needham on overextended consensus
05/26/21 Needham
Boston Scientific downgraded to Hold from Buy at Needham
05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Boston Scientific initiated with an Overweight at Barclays
PDD Pinduoduo
$130.83 /

+0.02 (+0.02%)

05/05/21 Daiwa
Pinduoduo initiated with a Buy at Daiwa
04/20/21 China Renaissance
Pinduoduo downgraded to Hold from Buy at China Renaissance
03/18/21
Fly Intel: Top five analyst downgrades
03/18/21 Benchmark
Pinduoduo price target raised to $176 from $150 at Benchmark
AMC AMC Entertainment
$16.41 /

-0.005 (-0.03%)

05/26/21 B. Riley
AMC Entertainment downgraded to Neutral from Buy at B. Riley
05/25/21 Citi
Citi boosts AMC target to $3.70, says shares remain overvalued
05/14/21 B. Riley
AMC Entertainment price target raised to $16 from $13 at B. Riley
04/16/21 B. Riley
AMC CEO update on share issuance a positive, says B. Riley
BB BlackBerry
$8.59 /

+ (+0.00%)

03/31/21
Fly Intel: Top five analyst upgrades
03/31/21 Canaccord
BlackBerry upgraded to Hold from Sell at Canaccord
02/16/21
Fly Intel: Top five analyst downgrades
02/16/21 Canaccord
BlackBerry cut to Sell after 'targeted short squeeze' at Canaccord
GME GameStop
$209.31 /

+ (+0.00%)

04/12/21
Fly Intel: Top five analyst downgrades
04/12/21 Ascendiant
GameStop downgraded to Sell from Hold at Ascendiant
04/06/21 BofA
BofA keeps $10 target on GameStop despite 'positive' funding news
04/05/21 Telsey Advisory
Telsey keeps Underperform rating on GameStop after Q1 update, ATM program bump
F Ford
$12.81 /

+ (+0.00%)

05/25/21 Goldman Sachs
Lordstown Motors price target lowered to $8 from $10 at Goldman Sachs
05/21/21 Morgan Stanley
Morgan Stanley says F-150 Lightning priced lower, coming sooner than expected
05/20/21 Wolfe Research
Wolfe downgrades Lordstown to sell with $1 target after Ford reveal
05/18/21 Tudor Pickering
Tudor Pickering starts Ford at Buy on EBIT margin improvement
GPS Gap
$32.67 /

+ (+0.00%)

05/25/21 Morgan Stanley
Gap price target raised to $33 ahead of earnings at Morgan Stanley
05/18/21
Fly Intel: Top five analyst upgrades
05/18/21 Credit Suisse
Gap upgraded to Neutral from Underperform at Credit Suisse
05/18/21 UBS
Gap price target raised to $38 from $28 at UBS
SIRI Sirius XM
$6.00 /

+ (+0.00%)

PDD Pinduoduo
$130.83 /

+0.02 (+0.02%)

GPS Gap
$32.67 /

+ (+0.00%)

GME GameStop
$209.31 /

+ (+0.00%)

F Ford
$12.81 /

+ (+0.00%)

EXPR Express
$3.95 /

+ (+0.00%)

BSX Boston Scientific
$43.03 /

-0.005 (-0.01%)

BB BlackBerry
$8.59 /

+ (+0.00%)

AMC AMC Entertainment
$16.41 /

-0.005 (-0.03%)

  • 11
    Dec
  • 18
    Nov
SIRI Sirius XM
$6.00 /

+ (+0.00%)

PDD Pinduoduo
$130.83 /

+0.02 (+0.02%)

GPS Gap
$32.67 /

+ (+0.00%)

GME GameStop
$209.31 /

+ (+0.00%)

F Ford
$12.81 /

+ (+0.00%)

EXPR Express
$3.95 /

+ (+0.00%)

BB BlackBerry
$8.59 /

+ (+0.00%)

AMC AMC Entertainment
$16.41 /

-0.005 (-0.03%)

SIRI Sirius XM
$6.00 /

+ (+0.00%)

PDD Pinduoduo
$130.83 /

+0.02 (+0.02%)

NBRV Nabriva Therapeutics
$1.50 /

+ (+0.00%)

GPS Gap
$32.67 /

+ (+0.00%)

GME GameStop
$209.31 /

+ (+0.00%)

F Ford
$12.81 /

+ (+0.00%)

EXPR Express
$3.95 /

+ (+0.00%)

BSX Boston Scientific
$43.03 /

-0.005 (-0.01%)

BB BlackBerry
$8.59 /

+ (+0.00%)

AMC AMC Entertainment
$16.41 /

-0.005 (-0.03%)

SIRI Sirius XM
$6.00 /

+ (+0.00%)

PDD Pinduoduo
$130.83 /

+0.02 (+0.02%)

NBRV Nabriva Therapeutics
$1.50 /

+ (+0.00%)

GPS Gap
$32.67 /

+ (+0.00%)

GME GameStop
$209.31 /

+ (+0.00%)

F Ford
$12.81 /

+ (+0.00%)

EXPR Express
$3.95 /

+ (+0.00%)

BSX Boston Scientific
$43.03 /

-0.005 (-0.01%)

BB BlackBerry
$8.59 /

+ (+0.00%)

AMC AMC Entertainment
$16.41 /

-0.005 (-0.03%)

Downgrade
Boston Scientific downgraded to Hold at Needham on overextended consensus » 07:20
05/26/21
05/26
07:20
05/26/21
07:20
BSX

Boston Scientific

$43.03 /

+0.215 (+0.50%)

, ABT

Abbott

$118.43 /

+1.13 (+0.96%)

As previously reported,…

As previously reported, Needham analyst Mike Matson downgraded Boston Scientific (BSX) to Hold from Buy. The analyst contends that consensus estimates for the company's 2022 and 2023 performance look "too high", anticipating downward revisions going into and out of Boston Scientific's investor day in September. Matson adds that Abbott's (ABT) upcoming Amulet left atrial appendage closure device launch could cause Boston Scientific's WATCHMAN growth to slow, and he sees the company's annual operating margin improvement close to 50bps than 100bps.

ShowHide Related Items >><<
BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

ABT Abbott
$118.43 /

+1.13 (+0.96%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

05/26/21 Needham
Boston Scientific downgraded to Hold from Buy at Needham
05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Boston Scientific initiated with an Overweight at Barclays
05/06/21 Raymond James
Abiomed could face new competition from Boston Scientific, says Raymond James
ABT Abbott
$118.43 /

+1.13 (+0.96%)

05/24/21 Barclays
Abbott initiated with an Overweight at Barclays
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

ABT Abbott
$118.43 /

+1.13 (+0.96%)

ABT Abbott
$118.43 /

+1.13 (+0.96%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

ABT Abbott
$118.43 /

+1.13 (+0.96%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

ABT Abbott
$118.43 /

+1.13 (+0.96%)

Downgrade
Boston Scientific downgraded to Hold from Buy at Needham » 05:29
05/26/21
05/26
05:29
05/26/21
05:29
BSX

Boston Scientific

$43.03 /

+0.215 (+0.50%)

Needham analyst Mike…

Needham analyst Mike Matson downgraded Boston Scientific to Hold from Buy without a price target.

ShowHide Related Items >><<
BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Boston Scientific initiated with an Overweight at Barclays
05/06/21 Raymond James
Abiomed could face new competition from Boston Scientific, says Raymond James
04/29/21 Truist
Boston Scientific price target raised to $50 from $42 at Truist
BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

Conference/Events
UBS to hold a virtual conference » 04:55
05/26/21
05/26
04:55
05/26/21
04:55
NBTX

Nanobiotix

$16.16 /

+ (+0.00%)

, MRNA

Moderna

$169.25 /

+5.16 (+3.14%)

, TELA

Tela Bio

$13.85 /

+0.6 (+4.53%)

, ICLR

Icon

$229.34 /

-2.74 (-1.18%)

, AMWL

Amwell

$11.89 /

+0.38 (+3.30%)

, BRKR

Bruker

$69.86 /

+0.12 (+0.17%)

, SIOX

Sio Gene Therapies

$2.22 /

+0.01 (+0.45%)

, BMRN

BioMarin

$77.60 /

+0.08 (+0.10%)

, NVS

Novartis

$88.51 /

+0.51 (+0.58%)

, TERN

Terns Pharmaceuticals

$15.39 /

-0.62 (-3.87%)

, EAR

Eargo

$32.10 /

-1.12 (-3.37%)

, JAZZ

Jazz Pharmaceuticals

$177.71 /

-1.17 (-0.65%)

, TNDM

TNDM

/

+

, BAYRY

Bayer

$16.93 /

-0.265 (-1.54%)

, ANIK

Anika Therapeutics

$43.66 /

-0.55 (-1.24%)

, CVAC

CureVac

$115.64 /

+1.27 (+1.11%)

, BSX

Boston Scientific

$43.03 /

+0.215 (+0.50%)

, APLT

Applied Therapeutics

$18.57 /

+1.06 (+6.05%)

, ARVN

Arvinas

$65.15 /

-0.78 (-1.18%)

, PACB

Pacific Biosciences

$25.68 /

-0.1 (-0.39%)

, ABBV

AbbVie

$114.56 /

-1.35 (-1.16%)

, ZYXI

Zynex

$14.12 /

-0.61 (-4.14%)

, BAX

Baxter

$82.34 /

-0.42 (-0.51%)

, KOD

Kodiak Sciences

$82.62 /

+1.66 (+2.05%)

, ARWR

Arrowhead

$73.96 /

-0.83 (-1.11%)

, CUTR

Cutera

$36.98 /

-1.15 (-3.02%)

, TVTY

Tivity Health

$25.73 /

-0.09 (-0.35%)

, PTCT

PTC Therapeutics

$39.66 /

+0.52 (+1.33%)

, CTLT

Catalent

$103.45 /

+0.88 (+0.86%)

, RHHBY

Roche

$43.57 /

+ (+0.00%)

, CLPT

ClearPoint Neuro

$18.07 /

-0.38 (-2.06%)

, BNTX

BioNTech

$197.53 /

+2.64 (+1.35%)

, ALGN

Align Technology

$594.91 /

-9.47 (-1.57%)

, DBTX

Decibel Therapeutics

$7.85 /

-0.205 (-2.55%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference 2021 to be held on May 24-26.Webcast Link

ShowHide Related Items >><<
ZYXI Zynex
$14.12 /

-0.61 (-4.14%)

TVTY Tivity Health
$25.73 /

-0.09 (-0.35%)

TNDM TNDM
/

+

TERN Terns Pharmaceuticals
$15.39 /

-0.62 (-3.87%)

TELA Tela Bio
$13.85 /

+0.6 (+4.53%)

SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

RHHBY Roche
$43.57 /

+ (+0.00%)

PTCT PTC Therapeutics
$39.66 /

+0.52 (+1.33%)

PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

NVS Novartis
$88.51 /

+0.51 (+0.58%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

KOD Kodiak Sciences
$82.62 /

+1.66 (+2.05%)

JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

ICLR Icon
$229.34 /

-2.74 (-1.18%)

DBTX Decibel Therapeutics
$7.85 /

-0.205 (-2.55%)

CVAC CureVac
$115.64 /

+1.27 (+1.11%)

CUTR Cutera
$36.98 /

-1.15 (-3.02%)

CTLT Catalent
$103.45 /

+0.88 (+0.86%)

CLPT ClearPoint Neuro
$18.07 /

-0.38 (-2.06%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

BRKR Bruker
$69.86 /

+0.12 (+0.17%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

BAX Baxter
$82.34 /

-0.42 (-0.51%)

ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

ARVN Arvinas
$65.15 /

-0.78 (-1.18%)

APLT Applied Therapeutics
$18.57 /

+1.06 (+6.05%)

AMWL Amwell
$11.89 /

+0.38 (+3.30%)

ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
MRNA Moderna
$169.25 /

+5.16 (+3.14%)

05/21/21 Piper Sandler
Piper says overseas approvals providing 'second leg of growth' for Moderna
05/07/21 Barclays
Moderna price target raised to $194 from $178 at Barclays
05/07/21 Goldman Sachs
Moderna price target raised to $228 from $206 at Goldman Sachs
05/06/21 Piper Sandler
Moderna price target lowered to $231 from $234 at Piper Sandler
TELA Tela Bio
$13.85 /

+0.6 (+4.53%)

04/12/21 Piper Sandler
Reviews of Tela Bio's OviTex from two KOLs were positive, says Piper Sandler
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
03/25/21 Canaccord
Tela Bio pieces in place for accelerating growth, says Canaccord
01/14/21 Piper Sandler
Piper says Tela Bio momentum looks 'healthy' despite 'slight' Q4 miss
ICLR Icon
$229.34 /

-2.74 (-1.18%)

05/10/21 Truist
PRA Health downgraded to Hold from Buy at Truist
05/03/21 Mizuho
Icon price target raised to $242 from $217 at Mizuho
04/29/21 Credit Suisse
Icon price target raised to $245 from $240 at Credit Suisse
04/20/21 Baird
PRA Health downgraded to Neutral from Outperform at Baird
AMWL Amwell
$11.89 /

+0.38 (+3.30%)

05/17/21 Guggenheim
Amwell upgraded to Buy from Neutral at Guggenheim
05/13/21 Piper Sandler
Amwell price target lowered to $20 from $30 at Piper Sandler
05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
BRKR Bruker
$69.86 /

+0.12 (+0.17%)

05/06/21 BTIG
Bruker price target raised to $80 from $73 at BTIG
05/06/21 SVB Leerink
Bruker price target raised to $80 from $70 at SVB Leerink
02/17/21 Stifel
Bruker price target raised to $65 from $48 at Stifel
02/17/21 Citi
Bruker price target raised to $65 from $57 at Citi
SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

04/30/21 Wedbush
BioMarin's Q1 revenue was better than expected, says Wedbush
04/26/21 Credit Suisse
BioMarin assumed with an Outperform at Credit Suisse
03/04/21 Guggenheim
BioMarin assumed at Buy from Neutral at Guggenheim
03/01/21 Evercore ISI
BioMarin upgraded to Outperform from In Line at Evercore ISI
NVS Novartis
$88.51 /

+0.51 (+0.58%)

05/11/21 Morgan Stanley
Novartis price target lowered to CHF 99 from CHF 102 at Morgan Stanley
04/28/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 85 at JPMorgan
04/28/21 Oddo BHF
Novartis upgraded to Outperform from Neutral at Oddo BHF
04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
TERN Terns Pharmaceuticals
$15.39 /

-0.62 (-3.87%)

03/02/21 Cowen
Terns initiated with Outperform on NASH potential at Cowen
03/02/21 JPMorgan
Terns Pharmaceuticals initiated with an Overweight at JPMorgan
03/02/21 Cowen
Terns Pharmaceuticals initiated with an Outperform at Cowen
03/02/21 Goldman Sachs
Terns Pharmaceuticals initiated with a Buy at Goldman Sachs
EAR Eargo
$32.10 /

-1.12 (-3.37%)

05/13/21 Wells Fargo
Eargo price target lowered to $52 from $68 at Wells Fargo
05/12/21 JPMorgan
JPMorgan sees four 'compelling' MedTech opportunities after selloff
01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
TNDM TNDM
/

+

05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Tandem Diabetes initiated with an Underweight at Barclays
05/06/21 SVB Leerink
Tandem Diabetes price target raised to $102 from $95 at SVB Leerink
05/06/21 Oppenheimer
Tandem Diabetes price target raised to $135 from $130 at Oppenheimer
BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

05/19/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
05/19/21 JPMorgan
JPMorgan upgrades Bayer to Overweight with earnings at 'turning point'
05/18/21 JPMorgan
Bayer upgraded to Overweight from Neutral at JPMorgan
05/14/21 Berenberg
Bayer price target raised to EUR 74 from EUR 68 at Berenberg
ANIK Anika Therapeutics
$43.66 /

-0.55 (-1.24%)

12/16/20 Barrington
Anika Therapeutics upgraded to Outperform with $43 target at Barrington
12/16/20 Barrington
Anika Therapeutics upgraded to Outperform from Market Perform at Barrington
CVAC CureVac
$115.64 /

+1.27 (+1.11%)

04/26/21 Credit Suisse
CureVac assumed with an Underperform at Credit Suisse
04/26/21 Guggenheim
CureVac initiated with a Buy at Guggenheim
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

05/24/21 Barclays
Boston Scientific initiated with an Overweight at Barclays
05/06/21 Raymond James
Abiomed could face new competition from Boston Scientific, says Raymond James
04/29/21 Truist
Boston Scientific price target raised to $50 from $42 at Truist
APLT Applied Therapeutics
$18.57 /

+1.06 (+6.05%)

11/17/20 Barclays
Applied Therapeutics price target lowered to $44 from $64 at Barclays
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
ARVN Arvinas
$65.15 /

-0.78 (-1.18%)

05/20/21 UBS
Arvinas initiated with a Buy at UBS
04/21/21 Truist
Truist starts Arvinas with a Buy on PROTACs potential
04/21/21 Truist
Arvinas initiated with a Buy at Truist
03/31/21 BMO Capital
Arvinas initiated with an Outperform at BMO Capital
PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

03/31/21 Piper Sandler
Illumina should be bought on weakness from FTC challenge, says Piper Sandler
02/11/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald
02/11/21 Piper Sandler
Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler
01/15/21 Piper Sandler
Pacific Biosciences price target raised to $20 from $12 at Piper Sandler
ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

05/19/21 Piper Sandler
Piper 'incrementally bullish' on Biohaven, AbbVie migraine drugs
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
ZYXI Zynex
$14.12 /

-0.61 (-4.14%)

04/29/21 Piper Sandler
Zynex price target lowered to $15 from $19 at Piper Sandler
03/09/21 Northland
Zynex upgraded to Outperform from Market Perform at Northland
02/26/21 B. Riley
B. Riley downgrades Zynex to Neutral on 'deteriorating profitability'
02/26/21 B. Riley
Zynex downgraded to Neutral from Buy at B. Riley Securities
BAX Baxter
$82.34 /

-0.42 (-0.51%)

05/24/21 Barclays
Baxter initiated with an Equal Weight at Barclays
04/30/21 Citi
Baxter price target raised to $98 from $94 at Citi
04/29/21 Piper Sandler
Baxter price target raised to $85 from $80 at Piper Sandler
KOD Kodiak Sciences
$82.62 /

+1.66 (+2.05%)

05/11/21 Roth Capital
Roth Capital upgrades Kodiak Sciences to Buy on recent selloff
05/11/21 Roth Capital
Kodiak Sciences upgraded to Buy from Neutral at Roth Capital
05/11/21 BMO Capital
Kodiak Sciences price target lowered to $104 from $138 at BMO Capital
05/11/21 Barclays
Kodiak Sciences price target lowered to $86 from $90 at Barclays
ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

02/08/21 B. Riley
Arrowhead price target raised to $106 from $98 at B. Riley Securities
02/08/21 Citi
Arrowhead price target raised to $110 from $90 at Citi
02/05/21 Chardan
Arrowhead price target raised to $97 from $81 at Chardan
02/05/21 H.C. Wainwright
Arrowhead price target raised to $95 from $90 at H.C. Wainwright
CUTR Cutera
$36.98 /

-1.15 (-3.02%)

03/05/21 Piper Sandler
Cutera price target raised to $42 from $38 at Piper Sandler
02/18/21 Piper Sandler
Cutera price target raised to $38 from $28 at Piper Sandler
11/05/20 Piper Sandler
Cutera price target raised to $28 from $22 at Piper Sandler
09/14/20 Stephens
Cutera price target raised to $24 from $18 at Stephens
TVTY Tivity Health
$25.73 /

-0.09 (-0.35%)

02/25/21 Barrington
Tivity Health price target raised to $32 from $28 at Barrington
02/25/21 Piper Sandler
Tivity Health price target raised to $27 from $16 at Piper Sandler
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform with $19 target at Credit Suisse
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform from Neutral at Credit Suisse
PTCT PTC Therapeutics
$39.66 /

+0.52 (+1.33%)

05/17/21 Truist
PTC Therapeutics price target lowered to $65 from $75 at Truist
04/26/21 Credit Suisse
PTC Therapeutics assumed with a Neutral at Credit Suisse
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
CTLT Catalent
$103.45 /

+0.88 (+0.86%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/02/21 Argus
Catalent price target raised to $140 from $130 at Argus
02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
RHHBY Roche
$43.57 /

+ (+0.00%)

05/05/21 BTIG
Mereo BioPharma initiated with a Buy at BTIG
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
CLPT ClearPoint Neuro
$18.07 /

-0.38 (-2.06%)

03/18/21 Lake Street
Lake Street starts ClearPoint Neuro at Buy, sees 'billion-dollar' cap potential
03/18/21 Lake Street
ClearPoint Neuro initiated with a Buy at Lake Street
02/22/21 B. Riley
ClearPoint Neuro price target raised to $38 from $23 at B. Riley Securities
01/22/21 B. Riley
ClearPoint Neuro price target raised to $23 from $18 at B. Riley Securities
BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
05/11/21
Fly Intel: Top five analyst downgrades
ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

04/29/21 SVB Leerink
Align Technology price target raised to $770 from $690 at SVB Leerink
04/29/21 Credit Suisse
Align Technology price target raised to $715 from $693 at Credit Suisse
04/29/21 Stifel
Align Technology price target raised to $750 from $650 at Stifel
04/29/21 Baird
Align Technology price target raised to $745 from $655 at Baird
DBTX Decibel Therapeutics
$7.85 /

-0.205 (-2.55%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
ZYXI Zynex
$14.12 /

-0.61 (-4.14%)

TVTY Tivity Health
$25.73 /

-0.09 (-0.35%)

TNDM TNDM
/

+

TELA Tela Bio
$13.85 /

+0.6 (+4.53%)

SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

RHHBY Roche
$43.57 /

+ (+0.00%)

PTCT PTC Therapeutics
$39.66 /

+0.52 (+1.33%)

PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

NVS Novartis
$88.51 /

+0.51 (+0.58%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

KOD Kodiak Sciences
$82.62 /

+1.66 (+2.05%)

JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

ICLR Icon
$229.34 /

-2.74 (-1.18%)

EAR Eargo
$32.10 /

-1.12 (-3.37%)

CUTR Cutera
$36.98 /

-1.15 (-3.02%)

CTLT Catalent
$103.45 /

+0.88 (+0.86%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

BRKR Bruker
$69.86 /

+0.12 (+0.17%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

BAX Baxter
$82.34 /

-0.42 (-0.51%)

ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

ARVN Arvinas
$65.15 /

-0.78 (-1.18%)

APLT Applied Therapeutics
$18.57 /

+1.06 (+6.05%)

AMWL Amwell
$11.89 /

+0.38 (+3.30%)

ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

  • 19
    Feb
  • 12
    Feb
  • 12
    Feb
  • 05
    Feb
  • 28
    Jan
  • 15
    Jan
  • 16
    Dec
  • 11
    Dec
  • 23
    Nov
  • 18
    Nov
  • 11
    Nov
  • 21
    Oct
  • 16
    Oct
  • 17
    Sep
  • 12
    Aug
  • 14
    Aug
  • 23
    Jul
  • 15
    Jul
  • 26
    Jun
  • 11
    Jun
RHHBY Roche
$43.57 /

+ (+0.00%)

PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

NVS Novartis
$88.51 /

+0.51 (+0.58%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

ICLR Icon
$229.34 /

-2.74 (-1.18%)

CVAC CureVac
$115.64 /

+1.27 (+1.11%)

CTLT Catalent
$103.45 /

+0.88 (+0.86%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

BAX Baxter
$82.34 /

-0.42 (-0.51%)

ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

TERN Terns Pharmaceuticals
$15.39 /

-0.62 (-3.87%)

SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

RHHBY Roche
$43.57 /

+ (+0.00%)

PTCT PTC Therapeutics
$39.66 /

+0.52 (+1.33%)

NVS Novartis
$88.51 /

+0.51 (+0.58%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

ICLR Icon
$229.34 /

-2.74 (-1.18%)

DBTX Decibel Therapeutics
$7.85 /

-0.205 (-2.55%)

CVAC CureVac
$115.64 /

+1.27 (+1.11%)

CTLT Catalent
$103.45 /

+0.88 (+0.86%)

CLPT ClearPoint Neuro
$18.07 /

-0.38 (-2.06%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

BRKR Bruker
$69.86 /

+0.12 (+0.17%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

BAX Baxter
$82.34 /

-0.42 (-0.51%)

ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

ARVN Arvinas
$65.15 /

-0.78 (-1.18%)

APLT Applied Therapeutics
$18.57 /

+1.06 (+6.05%)

AMWL Amwell
$11.89 /

+0.38 (+3.30%)

ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

ZYXI Zynex
$14.12 /

-0.61 (-4.14%)

SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

EAR Eargo
$32.10 /

-1.12 (-3.37%)

CVAC CureVac
$115.64 /

+1.27 (+1.11%)

CLPT ClearPoint Neuro
$18.07 /

-0.38 (-2.06%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

AMWL Amwell
$11.89 /

+0.38 (+3.30%)

ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

Hot Stocks
Boston Scientific completes CE Mark for EXALT Model B Single-Use Bronchoscope » 06:56
05/25/21
05/25
06:56
05/25/21
06:56
BSX

Boston Scientific

$42.81 /

+0.705 (+1.67%)

Boston Scientific…

Boston Scientific announced it has completed CE Mark for the EXALT Model B Single-Use Bronchoscope, a single-use device designed for bedside procedures in the intensive care unit, operating room and bronchoscopy suite. Limited market release of the device is expected to commence in Europe in the coming weeks.

ShowHide Related Items >><<
BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Boston Scientific initiated with an Overweight at Barclays
05/06/21 Raymond James
Abiomed could face new competition from Boston Scientific, says Raymond James
04/29/21 Truist
Boston Scientific price target raised to $50 from $42 at Truist
BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.